Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype:: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype

被引:38
作者
Candore, G
Modica, MA
Lio, D
Colonna-Romano, G
Listì, F
Grimaldi, MP
Russo, M
Triolo, G
Accardo-Palumbo, A
Cuccia, MC
Caruso, C
机构
[1] Dipartimento Biopatol & Metodol Biomed, Lab Immunopatol, I-90134 Palermo, Italy
[2] Univ Palermo, Ist Clin Med, I-90133 Palermo, Italy
[3] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy
关键词
AH; 8.1; C4; HLA-B8; DR3; CIRCULATING IMMUNE-COMPLEXES; CLASS-III REGION; HLA; COMPLEMENT; POPULATION; ORGANIZATION; LONGEVITY;
D O I
10.1016/S0753-3322(03)00079-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Subjects with certain HLA alleles have a higher risk of specific autoimmune diseases than those without these alleles. The 8.1 ancestral haplotype (AH) is a common Caucasoid haplotype carried by most people who type for HLA-B8,DR3. It is unique in its association with a wide range of immunopathological diseases. To gain insight into the identification of the mechanism(s) of disease susceptibility of 8.1 AH carriers, we have investigated the prevalence of circulating immune complexes and non-organ-specific autoantibodies in healthy carriers of the haplotype. The results show that carriers of 8.1 AH display both a significant increased prevalence of immune complexes and higher titers of anti-nuclear autoantibodies. This AH carries a single segment characterized by no C4A gene. This null allele does not code for a functional C4A protein that likely plays an anti-inflammatory role being specialized in the opsonization and immunoclearance processes. So, this genetic defect has been claimed to allow that an increased production of autoantibodies directed vs. cells that have undergone apoptosis and are not efficiently disposed because A reduced antigenic clearance. The results obtained in the present study fit very well with this hypothesis. In the AH carriers the simultaneous high setting of tumor necrosis factor (TNF)-alpha may supply the autoantigens (providing an excess of apoptotic cells) that drive the autoimmune response. In conclusion, the C4 defect associated to the increased spontaneous release of TNF-alpha modifying a certain number of immunological parameter may be the most characterizing feature of the 8.1 AH. In the majority of individuals, an autoimmune response clinically relevant will develop only in the presence of other immunological abnormalities. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 20 条
[1]   INHERITED STRUCTURAL POLYMORPHISM OF THE 4TH COMPONENT OF HUMAN-COMPLEMENT [J].
AWDEH, ZL ;
ALPER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3576-3580
[2]  
Candore G, 2002, ARCH GERONTOL GERIAT, P75
[3]  
CANDORE G, 2002, AUTOIMMUN REV, V1, P313
[4]   HLA, aging, and longevity:: A critical reappraisal [J].
Caruso, C ;
Candore, G ;
Romano, GC ;
Lio, D ;
Bonafè, M ;
Valensin, S ;
Franceschi, C .
HUMAN IMMUNOLOGY, 2000, 61 (09) :942-949
[5]  
DALFONSO S, 1994, IMMUNOGENETICS, V39, P114
[6]   ANCESTRAL HAPLOTYPES - CONSERVED POPULATION MHC HAPLOTYPES [J].
DEGLIESPOSTI, MA ;
LEAVER, AL ;
CHRISTIANSEN, FT ;
WITT, CS ;
ABRAHAM, LJ ;
DAWKINS, RL .
HUMAN IMMUNOLOGY, 1992, 34 (04) :242-252
[7]  
Dondi E, 1996, FUND CLIN IMMUNOL, V4, P73
[8]   Association between the HLA-DR alleles and longevity:: a study in Sardinian population [J].
Lio, D ;
Pes, GM ;
Carru, C ;
Listì, F ;
Ferlazzo, V ;
Candore, G ;
Colonna-Romano, G ;
Ferrucci, L ;
Deiana, L ;
Baggio, G ;
Franceschi, C ;
Caruso, C .
EXPERIMENTAL GERONTOLOGY, 2003, 38 (03) :313-317
[9]   A genetically determined high setting of TNF-α influences immunologic parameters of HLA-B8,DR3 positive subjects:: Implications for autoimmunity [J].
Lio, D ;
Candore, G ;
Colombo, A ;
Romano, GC ;
Gervasi, F ;
Marino, V ;
Scola, L ;
Caruso, C .
HUMAN IMMUNOLOGY, 2001, 62 (07) :705-713
[10]   Tumor necrosis factor locus: Genetic organisation and biological implications [J].
Makhatadze, NJ .
HUMAN IMMUNOLOGY, 1998, 59 (09) :571-579